BioHarvest Sciences Inc. Common Stock (BHST) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.58M | -2.25M | -2.11M | -1.51M | -1.43M | -2.95M | -1.76M | -958K | -1.58M | -2.89M | -995K | -2.88M |
| Operating CF Margin % | -18.54% | -24.84% | -23.32% | -17.72% | -18.16% | -40.51% | -26.9% | -15.9% | -29.53% | -64.02% | -30.72% | -104.65% |
| Operating CF Growth % | -10.51% | 23.62% | -20.19% | -57.48% | 9.57% | -1.9% | -76.78% | 66.71% | 4.65% | -28.96% | 60.17% | -65.78% |
| Net Income | -2.64M | -2.2M | -2.51M | -4.08M | -2.34M | -2.96M | -2.69M | -687K | -6.58M | -7.24M | -1.73M | -2.85M |
| Depreciation & Amortization | 428K | 433K | 385K | 407K | 399K | 341K | 351K | 357K | 202K | 218K | 217K | 209K |
| Stock-Based Compensation | 0 | 148K | 0 | 0 | 132K | 0 | 126K | 195K | 133K | 0 | 118K | 189K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 627K | 899K | 794.7K | 1.81M | 369K | 34.9K | 477.11K | -1.17M | 5.16M | 4.43M | -341K | -138K |
| Working Capital Changes | 9K | -1.53M | -780.76K | 349.46K | 11K | -368.38K | -24.11K | 344K | -496K | -310.26K | 738K | -288K |
| Change in Receivables | -274K | -477K | 35.51K | -254.07K | -419K | 210K | -507K | -75K | -213K | -141.3K | -3K | -31K |
| Change in Inventory | -412K | -125K | -310.24K | -123.62K | -357K | -445.6K | -620K | 108K | -210K | -378.22K | -82K | -135K |
| Change in Payables | 712K | 0 | 55.64K | 864.59K | 0 | -316.96K | 0 | 0 | 0 | 209.26K | 0 | 0 |
| Cash from Investing | -1.59M | -668K | -427.6K | -615.22K | -680K | -348.58K | -472K | -1.93M | -222K | -272.69K | -440K | -367K |
| Capital Expenditures | -593K | -654K | -427.59K | -615.29K | -684K | -344.77K | -512K | -1.71M | -222K | -272.69K | -440K | -367K |
| CapEx % of Revenue | 6.97% | 7.21% | 4.72% | 7.23% | 8.7% | 4.74% | 7.83% | 28.34% | 4.15% | 6.03% | 13.58% | 13.35% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1M | -14K | -13 | 73 | 4K | -3.81K | 40K | -225K | 0 | 0 | 0 | 0 |
| Cash from Financing | -642K | 14.94M | 9.87M | 2.49M | 3.12M | 3.01M | -164K | 4.61M | -116K | 6.86M | 1.18M | 4.75M |
| Debt Issued (Net) | -105K | -4.16M | 4.37M | 2.75M | 3.12M | 3.25M | -164K | -119K | -129K | 13.39M | 1.18M | 4.34M |
| Equity Issued (Net) | 0 | 19.26M | 5.93M | 0 | 0 | -78.04K | 15.07K | 0 | 0 | -5.34K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -537K | -159K | -429K | -264.71K | 0 | -156.81K | -15.07K | 4.72M | 13K | -6.53M | 0 | 403K |
| Net Change in Cash | -3.86M | 12.06M | 7.24M | 326K | 1.01M | -378K | -2.4M | 1.73M | -1.92M | 3.8M | -253K | 1.51M |
| Free Cash Flow | -2.17M | -2.91M | -2.54M | -2.12M | -2.11M | -3.29M | -2.27M | -2.67M | -1.8M | -3.17M | -1.44M | -3.25M |
| FCF Margin % | -25.51% | -32.05% | -28.03% | -24.94% | -26.86% | -45.25% | -34.73% | -44.23% | -33.68% | -70.05% | -44.3% | -118% |
| FCF Growth % | -2.79% | 11.76% | -11.92% | 20.33% | -17.28% | -4.01% | -58.26% | 17.84% | 11.37% | -28.05% | 48.33% | -57.6% |
| FCF per Share | -0.10 | -0.16 | -0.15 | -0.12 | -0.12 | -0.19 | -0.13 | -0.16 | -0.13 | -0.24 | -0.11 | -0.24 |
| FCF Conversion (FCF/Net Income) | 0.60x | 1.02x | 0.84x | 0.37x | 0.61x | 1.00x | 0.65x | 1.39x | 0.24x | 0.40x | 0.58x | 1.01x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |